Universal Ibogaine (FRA:JC4) EPS (Basic) : €-0.00 (TTM As of Apr. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Universal Ibogaine EPS (Basic)?

Universal Ibogaine's basic earnings per share (Basic EPS) for the three months ended in Apr. 2024 was €-0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Apr. 2024 was €-0.00.

Universal Ibogaine's EPS (Diluted) for the three months ended in Apr. 2024 was €-0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Apr. 2024 was €-0.00.

Universal Ibogaine's EPS without NRI for the three months ended in Apr. 2024 was €-0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Apr. 2024 was -0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Universal Ibogaine EPS (Basic) Historical Data

The historical data trend for Universal Ibogaine's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine EPS (Basic) Chart

Universal Ibogaine Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Jul22

Jul23

EPS (Basic)

Get a 7-Day Free Trial

-0.01

-0.02

-0.05

-0.01

Universal Ibogaine Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24
EPS (Basic)	Get a 7-Day Free Trial															-	-	-	-	-

Universal Ibogaine EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Universal Ibogaine's Basic EPS for the fiscal year that ended in Jul. 2023 is calculated as

Basic EPS (A: Jul. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-1.635	-	0)	/	191.298
	=	-0.01

Universal Ibogaine's Basic EPS for the quarter that ended in Apr. 2024 is calculated as

Basic EPS (Q: Apr. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.588	-	0)	/	284.452
	=	-0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Apr. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.00

Universal Ibogaine (FRA:JC4) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Universal Ibogaine EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Universal Ibogaine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (FRA:JC4) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

IBOGF:USA IBO:Canada

Address

815 8th Avenue South West, Suite 600, Calgary, AB, CAN, T2P 3P2

Website

https://www.universalibogaine.com

Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.

Universal Ibogaine Headlines

No Headlines